The FDA has approved Zyrtec-D for nonprescription use in adults and children 12 years of age and older. References and Resources FDA Approves Nonprescription Zyrtec-D for Allergies Click…
Mepolizumab, an IL-5 inhibitor, failed to alleviate moderate persistent asthma symptoms in a phase II trial of patients resistant to corticosteroids. References and Resources Flood-Page P, Swenson C,…